Squamous Cell Carcinoma of tonsil, stained with p16 BOND Ready-to-Use Primary Antibody (6H12), PA0016
Squamous Cell Carcinoma of tonsil, stained with p16 BOND Ready-to-Use Primary Antibody (6H12), PA0016
p16
Antigen Background p16 (INK4a) (Cyclin-dependent kinase inhibitor 2A (CDKN2A)) is a tumour suppressor protein associated with cell cycle progression, specifically in the regulation of transition from G1 phase of the cell cycle in to the S phase. Oncogenic mutations in the CDKN2A gene that encodes p16 (resulting in over or under expression of the protein) is associated with a wide range of cancers and cancer precursor lesions.
Disclaimer p16 is recommended for the detection of specific antigens of interest in normal and neoplastic tissues, as an adjunct to conventional histopathology using non-immunologic histochemical stains.
Prodotti
Prodotti
PA0016
7mL p16 (6H12) BOND RTU Primary
Product is out of stock
Due to manufacturing & supply chain issues, this product is currently unavailable. You may place your order and it will be fulfilled when the product is back in stock. For more help, please reach out to customer service at +1 844 534 2262 or nonurgentcs@leicabiosystems.com
Product is limited in stock
Product availability is limited, but products are in continuous production. Your order will be processed as normal and may take additional days to ship.